2,4,6-Triisopropylbenzenesulfonyl Azide

We are 2,4,6-Triisopropylbenzenesulfonyl Azide CAS:36982-84-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2,4,6-Triisopropylbenzenesulfonyl Azide
CAS.NO:36982-84-0
Synonyms:N-diazo-2,4,6-tri(propan-2-yl)benzenesulfonamide;TPS-N3
Molecular Formula:C15H23N3O2S
Molecular Weight:309.42700
 
Physical and Chemical Properties:
Melting point:40-42oC;
Boiling point:61oC;
Flash point:61oC;
 
HS Code: 2929909090
UN No.: UN1294
Hazard class: 6.1 categories 
Packing level: Class III
 
Specification:
Appearance:Off-white to white crystalline powder
Purity(HPLC):≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:As a condensation reagent
 

2,4,6-Triisopropylbenzenesulfonyl Azide


Related News: The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.529-19-1 Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,” Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.154748-67-1 Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.52123-54-3 Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.

Related Products
Product Name
5-Bromo-m-xylene View Details
5-Bromo-2-pyridinecarbonitrile View Details
2,6-Dichloropyridine View Details
3,5-Dichloro-2-fluoropyridine manufacturer 6-Chloro-5-fluoroindole manufacturer 1,3-Dichloropropane manufacturer 2-Aminobenzenesulfonic acid (1-methylethylidene)di-4,1-phenylene ester manufacturer Enfuvirtide manufacturer